J2267 – Injection, mirikizumab-mrkz, 1 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ2267
- Long description
- Injection, mirikizumab-mrkz, 1 mg
- Short description
- Inj, mirikizumab-mrkz, 1 mg
- Pricing indicator
51Drugs- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
O1EOther drugs- ASC
- Approved for ambulatory surgical centers
- Added
- July 1, 2024
- Last change
- July 1, 2024 – No change
Frequently asked questions
What is HCPCS code J2267?
J2267 is a HCPCS Level II code for injection, mirikizumab-mrkz, 1 mg.
Does Medicare cover J2267?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J2248 – Injection, micafungin sodium, 1 mg
- J2249 – Injection, remimazolam, 1 mg
- J2250 – Injection, midazolam hydrochloride, per 1 mg
- J2251 – Injection, midazolam in 0.9% sodium chloride, intravenous, not therapeutically equivalent to j2250, 1 mg
- J2252 – Injection, midazolam in 0.8% sodium chloride, intravenous, not therapeutically equivalent to j2250, 1 mg
- J2253 – Injection, midazolam (seizalam), 1 mg
- J2260 – Injection, milrinone lactate, 5 mg
- J2265 – Injection, minocycline hydrochloride, 1 mg
- J2270 – Injection, morphine sulfate, up to 10 mg
- J2271 – Injection, morphine sulfate, 100mg
- J2272 – Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg
- J2274 – Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg
- J2275 – Injection, morphine sulfate (preservative-free sterile solution), per 10 mg
- J2277 – Injection, motixafortide, 0.25 mg
- J2278 – Injection, ziconotide, 1 microgram
- J2280 – Injection, moxifloxacin, 100 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.